{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T17:06:25Z","timestamp":1786381585110,"version":"build-2736575974"},"reference-count":37,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,6]]},"abstract":"<jats:p>Implementation of mass drug administration (MDA) with ivermectin plus albendazole (ALB) for lymphatic filariasis (LF) has been delayed in central Africa because of the risk of serious adverse events in subjects with high <jats:italic>Loa loa<\/jats:italic> microfilaremia. We conducted a community trial to assess the impact of semiannual MDA with ALB (400 mg) alone on LF and soil-transmitted helminth (STH) infections in the Republic of Congo. Evaluation at 12 months showed that ALB MDA had not significantly reduced <jats:italic>Wuchereria bancrofti<\/jats:italic> antigenemia or microfilaria (mf) rates in the community (from 17.3% to 16.6% and from 5.3% to 4.2%, respectively). However, the geometric mean mf count in mf-positive subjects was reduced from 202.2 to 80.9 mf\/mL (60% reduction, <jats:italic>P<\/jats:italic> = 0.01). The effect of ALB was impressive in 38 subjects who were mf-positive at baseline and retested at 12 months: 37% had total mf clearance, and individual mf densities were reduced by 73.0%. MDA also dramatically reduced the hookworm infection rate in the community from 6.5% to 0.6% (91% reduction), with less impressive effects on <jats:italic>Ascaris<\/jats:italic> and <jats:italic>Trichuris<\/jats:italic>. These preliminary results suggest that semiannual community MDA with ALB is a promising strategy for controlling LF and STH in areas with coendemic loiasis.<\/jats:p>","DOI":"10.4269\/ajtmh.14-0661","type":"journal-article","created":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T02:53:20Z","timestamp":1426042400000},"page":"959-966","source":"Crossref","is-referenced-by-count":31,"title":["The Impact of Two Semiannual Treatments with Albendazole Alone on Lymphatic Filariasis and Soil-Transmitted Helminth Infections: A Community-Based Study in the Republic of Congo"],"prefix":"10.4269","volume":"92","author":[{"given":"S\u00e9bastien D. S.","family":"Pion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric B.","family":"Chesnais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bopda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Louya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter U.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Boussinesq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Missamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"R1","article-title":"Provisional strategy for interrupting lymphatic filariasis transmission in loiasis-endemic countries","author":"World Health Organization","year":"2012"},{"key":"R2","series-title":"PLoS Negl Trop Dis","first-page":"e317","article-title":"The global programme to eliminate lymphatic filariasis: health impact after 8 years","volume":"2","author":"Ottesen","year":"2008"},{"key":"R3","series-title":"Ann Soc Belg Med Trop","first-page":"47","article-title":"Essai th\u00e9rapeutique de l'ivermectine au cours de la loase \u00e0 moyenne et forte microfilar\u00e9mie","volume":"71","author":"Carme","year":"1991"},{"key":"R4","series-title":"Lancet","first-page":"18","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"Gardon","year":"1997"},{"issue":"(Suppl 1)","key":"R5","series-title":"Filaria J","first-page":"S4","article-title":"Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon","volume":"2","author":"Boussinesq","year":"2003"},{"key":"R6","series-title":"Parasit Vectors","first-page":"100","article-title":"The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: a half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases","volume":"3","author":"Addiss","year":"2010"},{"key":"R7","series-title":"Curr Opin Infect Dis","first-page":"617","article-title":"Elimination of lymphatic filariasis: do we have the drugs to complete the job?","volume":"23","author":"Bockarie","year":"2010"},{"key":"R8","series-title":"J Infect Dis","first-page":"202","article-title":"Albendazole in human loiasis: results of a double-blind, placebo-controlled trial","volume":"168","author":"Klion","year":"1993"},{"key":"R9","series-title":"Trans R Soc Trop Med Hyg","first-page":"332","article-title":"Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis","volume":"95","author":"Ismail","year":"2001"},{"key":"R10","series-title":"Filaria J","first-page":"15","article-title":"Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis","volume":"2","author":"Makunde","year":"2003"},{"issue":"(Suppl 1)","key":"R11","series-title":"Acta Trop","first-page":"S33","article-title":"Evaluation of effectiveness of diethylcarbamazine\/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters","volume":"120","author":"Wamae","year":"2011"},{"key":"R12","series-title":"Bull World Health Organ","first-page":"491","article-title":"Strategies and tools for the control\/elimination of lymphatic filariasis","volume":"75","author":"Ottesen","year":"1997"},{"key":"R13","series-title":"Adv Parasitol","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0065-308X(05)61010-X","article-title":"Lymphatic filariasis: treatment, control and elimination","volume":"61","author":"Ottesen","year":"2006"},{"key":"R14","series-title":"PLoS Negl Trop Dis","first-page":"e1984","article-title":"Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis","volume":"7","author":"Stolk","year":"2013"},{"key":"R15","series-title":"Southeast Asian J Trop Med Public Health","first-page":"402","article-title":"Comparison of effects of mass annual and biannual single dose therapy with diethylcarbamazine for the control of Malayan filariasis","volume":"22","author":"Panicker","year":"1991"},{"key":"R16","series-title":"Trop Med Parasitol","first-page":"335","article-title":"Single versus repeated doses of ivermectin and diethylcarbamazine for the treatment of Wuchereria bancrofti var. pacifica microfilaremia. Results at 12 months of a double-blind study","volume":"42","author":"Cartel","year":"1991"},{"key":"R17","series-title":"Trop Med Parasitol","first-page":"91","article-title":"Compared efficacy of repeated annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia. Final evaluation","volume":"43","author":"Cartel","year":"1992"},{"key":"R18","series-title":"Clin Infect Dis","first-page":"1229","article-title":"Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels","volume":"51","author":"Dembele","year":"2010"},{"key":"R19","series-title":"Clin Infect Dis","first-page":"1236","article-title":"Higher-dose, more frequent treatment of Wuchereria bancrofti","volume":"51","author":"Kazura","year":"2010"},{"key":"R20","series-title":"Am J Trop Med Hyg","first-page":"916","article-title":"Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen","volume":"89","author":"Chesnais","year":"2013"},{"key":"R21","series-title":"Guidelines for the Evaluation of Soil-Transmitted Helminthiases and Schistosomiasis at Community Level","author":"World Health Organization","year":"1998"},{"key":"R22","series-title":"Trop Med Int Health","first-page":"818","article-title":"Albendazole for the control and elimination of lymphatic filariasis: systematic review","volume":"10","author":"Critchley","year":"2005"},{"key":"R23","series-title":"Trans R Soc Trop Med Hyg","first-page":"437","article-title":"Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment","volume":"94","author":"Dunyo","year":"2000"},{"key":"R24","series-title":"Trans R Soc Trop Med Hyg","first-page":"94","article-title":"Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis","volume":"92","author":"Ismail","year":"1998"},{"key":"R25","series-title":"Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelminthic Drugs in Control Interventions: A Manual for Health Professionals and Programme Managers","author":"World Health Organization","year":"2006"},{"key":"R26","series-title":"Philos Trans R Soc Lond B Biol Sci","article-title":"The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths","volume":"369","author":"Anderson","year":"2014"},{"key":"R27","series-title":"Parasit Vectors","first-page":"1","article-title":"Can chemotherapy alone eliminate the transmission of soil transmitted helminths?","volume":"7","author":"Truscott","year":"2014"},{"key":"R28","series-title":"Am J Trop Med Hyg","first-page":"479","article-title":"Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren","volume":"60","author":"Beach","year":"1999"},{"key":"R29","series-title":"Ann Trop Med Parasitol","first-page":"501","article-title":"Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka","volume":"93","author":"Ismail","year":"1999"},{"key":"R30","series-title":"Clin Infect Dis","first-page":"1420","article-title":"Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial","volume":"51","author":"Knopp","year":"2010"},{"key":"R31","series-title":"Bull World Health Organ","first-page":"35","article-title":"A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp","volume":"81","author":"Belizario","year":"2003"},{"key":"R32","series-title":"Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases: Second WHO Report on Neglected Tropical Diseases: Summary","author":"World Health Organization","year":"2013"},{"key":"R33","series-title":"PLoS Negl Trop Dis","first-page":"e2708","article-title":"Pilot assessment of soil-transmitted helminthiasis in the context of transmission assessment surveys for lymphatic filariasis in Benin and Tonga","volume":"8","author":"Chu","year":"2014"},{"key":"R34","series-title":"Int J Parasitol","first-page":"1205","article-title":"Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control","volume":"34","author":"Albonico","year":"2004"},{"key":"R35","series-title":"Int J Parasitol Drugs Drug Resist","first-page":"14","article-title":"Is anthelmintic resistance a concern for the control of human soil-transmitted helminths?","volume":"14","author":"Vercruysse","year":"2011"},{"key":"R36","series-title":"PLoS Negl Trop Dis","first-page":"e948","article-title":"Assessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemic","volume":"5","author":"Vercruysse","year":"2011"},{"key":"R37","series-title":"Am J Trop Med Hyg","first-page":"1052","article-title":"Molecular and biological diagnostic tests for monitoring benzimidazole resistance in human soil-transmitted helminths","volume":"88","author":"Diawara","year":"2013"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/92\/5\/article-p959.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/92\/5\/article-p959.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/92\/5\/article-p959.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T19:21:37Z","timestamp":1723058497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/92\/5\/article-p959.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,6]]},"references-count":37,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.14-0661","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,6]]}}}